| Elective versus therapeutic neck dissection in node-negative oral cancer AK D’Cruz, R Vaish, N Kapre, M Dandekar, S Gupta, R Hawaldar, ... New England Journal of Medicine 373 (6), 521-529, 2015 | 1152 | 2015 |
| Breast-cancer screening—viewpoint of the IARC Working Group B Lauby-Secretan, C Scoccianti, D Loomis, L Benbrahim-Tallaa, ... New England journal of medicine 372 (24), 2353-2358, 2015 | 1018 | 2015 |
| Cancer mortality in India: a nationally representative survey R Dikshit, PC Gupta, C Ramasundarahettige, V Gajalakshmi, ... The Lancet 379 (9828), 1807-1816, 2012 | 729 | 2012 |
| Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer HJ Burstein, Y Sun, LY Dirix, Z Jiang, R Paridaens, AR Tan, A Awada, ... J Clin Oncol 28 (8), 1301-1307, 2010 | 631 | 2010 |
| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 559 | 2014 |
| Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial R Badwe, R Hawaldar, N Nair, R Kaushik, V Parmar, S Siddique, ... The lancet oncology 16 (13), 1380-1388, 2015 | 521 | 2015 |
| The growing burden of cancer in India: epidemiology and social context MK Mallath, DG Taylor, RA Badwe, GK Rath, V Shanta, CS Pramesh, ... The Lancet Oncology 15 (6), e205-e212, 2014 | 476 | 2014 |
| Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a … S Gupta, A Maheshwari, P Parab, U Mahantshetty, R Hawaldar, S Sastri, ... Journal of Clinical Oncology 36 (16), 1548-1555, 2018 | 397 | 2018 |
| Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010 BO Anderson, E Cazap, NS El Saghir, CH Yip, HM Khaled, IV Otero, ... The lancet oncology 12 (4), 387-398, 2011 | 389 | 2011 |
| Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: the NEfERT-T randomized clinical trial A Awada, R Colomer, K Inoue, I Bondarenko, RA Badwe, G Demetriou, ... JAMA oncology 2 (12), 1557-1564, 2016 | 318 | 2016 |
| The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016 PK Dhillon, P Mathur, A Nandakumar, C Fitzmaurice, GA Kumar, ... The Lancet Oncology 19 (10), 1289-1306, 2018 | 277 | 2018 |
| Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India SS Shastri, I Mittra, GA Mishra, S Gupta, R Dikshit, S Singh, RA Badwe Journal of the National Cancer Institute 106 (3), dju009, 2014 | 264 | 2014 |
| A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening I Mittra, GA Mishra, S Singh, S Aranke, P Notani, R Badwe, AB Miller, ... International journal of cancer 126 (4), 976-984, 2010 | 252 | 2010 |
| Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer RA Badwe, WM Gregory, MA Chaudary, MA Richards, AE Bentley, ... The Lancet 337 (8752), 1261-1264, 1991 | 244 | 1991 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 236 | 2021 |
| Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting: a meta-analysis JV Divatia, JS Vaidya, RA Badwe, RW Hawaldar The Journal of the American Society of Anesthesiologists 85 (5), 1055-1062, 1996 | 236 | 1996 |
| Delivery of affordable and equitable cancer care in India CS Pramesh, RA Badwe, BB Borthakur, M Chandra, EH Raj, T Kannan, ... The Lancet Oncology 15 (6), e223-e233, 2014 | 227 | 2014 |
| Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative NS El Saghir, CA Adebamowo, BO Anderson, RW Carlson, PA Bird, ... The Breast 20, S3-S11, 2011 | 214 | 2011 |
| Breast cancer in limited‐resource countries: diagnosis and pathology R Shyyan, S Masood, RA Badwe, KM Errico, L Liberman, V Ozmen, ... The breast journal 12, S27-S37, 2006 | 153 | 2006 |
| Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India J Ghosh, S Gupta, S Desai, T Shet, S Radhakrishnan, P Suryavanshi, ... Indian journal of cancer 48 (4), 391-396, 2011 | 151 | 2011 |
